Insider · CIK 0002103583
Allison Hagerman
Files at ONCY (ONCOLYTICS BIOTECH INC). First filing Feb 13, 2026, latest Feb 13, 2026.
In brief
Allison Hagerman files SEC Form 4 as officer at ONCY (ONCOLYTICS BIOTECH INC). Since Feb 13, 2026, Allison Hagerman has reported 1 open-market buy worth $8,298 and 0 open-market sells worth $0, the latest filed on Feb 13, 2026.
A track record needs three past buys with six months of prices behind them; Allison Hagerman has 0, so none is measured yet.
The newest scored trade: bought $8,298 of ONCY on Feb 12, 2026, filed Feb 13, 2026, scored 33 (weak). In the last 12 months: 1 buy worth $8,298 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ONCY: ONCOLYTICS BIOTECH INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | ONCOLYTICS BIOTECH INC | $8,298 10,000 shares | +10% | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ONCY ONCOLYTICS BIOTECH INC | AGrant or award Stock Optionderivative | +260,000 | $0.00 | $0 | 260,000 | Jun 3, 2026 |
| Feb 12, 2026 | ONCY ONCOLYTICS BIOTECH INC | POpen-market purchase Common Shares | +10,000 | $0.83 | $8,298 | 115,059 | Feb 13, 2026 |
Questions about Allison Hagerman
Answered from the filings on this page, as of the latest one.
Is Allison Hagerman buying or selling?
In the last 12 months Allison Hagerman reported 1 open-market buy worth $8,298 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $8,298 of ONCY on Feb 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Allison Hagerman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Allison Hagerman has 0.
Where does Allison Hagerman file Form 4?
Allison Hagerman has filed Form 4 at ONCY (ONCOLYTICS BIOTECH INC) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.